Aspire BioPharma (ASBP) Company Overview

Profile

Full Name:

Aspire Biopharma Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 11, 2022

Indexes:

Not included

Website:

http://aspirebiolabs.com

Description:

Aspire BioPharma focuses on developing innovative therapies for eye diseases, aiming to improve vision and quality of life for patients.

Key Details

Price

$0.77

Market Cap

$35.37 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.01(+40.00% YoY)

PE Ratio

-

Annual ROE

73.60%

Annual Debt To Equity

-0.74

Beta

9.30

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with ASBP included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.77
ASBP price is $0.77

Price All-time High

$14.01
ASBP price is currently -94.50% below its historical high of $14.01

Price Analysts Target

-
ASBP price consensus analysts' forecast is unknown

Price Most Recent Change

-6.78%
ASBP price was down -6.78% on Mar 5, 2025

Price YTD Change

-
ASBP price ytd change is unknown

Price 3-Year Change

-
ASBP price 3-year change is unknown

Market cap

Market Cap

$35.37 M
ASBP market capitalization is $35.37 million

Market Cap 3-Year Change

-
ASBP market capitalization 3-year change is unknown

Market Cap All-time High

$282.98 M
ASBP market capitalization is currently -87.50% below its historical high of $282.98 million

Market Cap Sector Rank

31.85%
ASBP market capitalization is higher than 31.85% of companies in Healthcare sector

Technical

Beta

9.30
ASBP beta is 9.30

200-day SMA

$5.67
ASBP price is currently -86.43% below its 200-day simple moving average

14-day RSI

12.06
ASBP 14-day relative strength index is 12.06

30-day Relative Volume

1.19
ASBP 30-day relative volume is 1.19

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
ASBP annual revenue value is unknown

Annual Revenue Analysts Estimate

-
ASBP annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
ASBP annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
ASBP annual revenue is unknown

Profit

Annual Gross Profit

$0.00
ASBP annual gross profit is $0.00

Annual Gross Margin

-
ASBP annual gross profit margin value is unknown

Annual Operating Profit

-$358.60 K
ASBP annual operating income is -$358.60 thousand

Annual Operating Margin

-
ASBP annual operating profit margin value is unknown

Annual Net Income

-$359.10 K
ASBP annual net profit is -$359.10 thousand

Annual Net Margin

-
ASBP annual net profit margin value is unknown

EPS

Annual EPS

-$0.01
ASBP annual earnings per share is -$0.01

Annual EPS Analysts Estimate

-
ASBP annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+40%
ASBP annual earnings per share is up +40% year-on-year

Annual EPS Sector Rank

-
ASBP annual earnings per share is unknown

ROA & ROE

Annual ROA

-777.27%
ASBP annual return on assets is -777.27%

Annual ROE

73.60%
ASBP annual return on equity is 73.60%

EBIT & EBITDA

Annual EBIT

-$358.60 K
ASBP annual earnings before interest & taxes is -$358.60 thousand

Annual EBITDA

-$358.60 K
ASBP annual EBITDA is -$358.60 thousand

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ASBP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ASBP price to earnings ratio is unknown

PB Ratio

PB Ratio

-44.13
ASBP price to book ratio is -44.13

PB Ratio Sector Rank

0.66%
ASBP price to book ratio is higher than 0.66% of companies in Healthcare sector

PS Ratio

PS Ratio

-
ASBP price to sales ratio value is unknown

PS Ratio Sector Rank

-
ASBP price to sales ratio is unknown

Enterprise value

Enterprise Value

$36.21 M
ASBP enterprise value is $36.21 million

Enterprise Value Sector Rank

36.07%
ASBP enterprise value is higher than 36.07% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-87.08
ASBP EV/EBITDA is -87.08

EV/EBITDA Sector Rank

1.59%
ASBP EV/EBITDA is higher than 1.59% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.09
ASBP annual current ratio is 0.09

Annual Quick Ratio

-
ASBP annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.74
ASBP annual debt to equity ratio is -0.74

Annual Interest Coverage Ratio

-
ASBP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ASBP piotroski f-score value is unknown

Altman Z-Score

-
ASBP altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$46.20 K
ASBP annual total assets is $46.20 thousand

Annual Non Current Assets

$0.00
ASBP annual long term assets is $0.00

Annual Current Assets

$46.20 K
ASBP annual total current assets is $46.20 thousand

Annual Cash & Cash Equivalents

$11.20 K
ASBP annual cash & cash equivalents is $11.20 thousand

Equity

Annual Book Value

-$487.90 K
ASBP annual book value is -$487.90 thousand

Annual Working Capital

-$487.80 K
ASBP annual working capital is -$487.80 thousand

Liabilities

Annual Total Liabilities

$534.00 K
ASBP annual total liabilities is $534.00 thousand

Annual Total Long Term Liabilities

$0.00
ASBP annual total long term liabilities is $0.00

Annual Current Liabilities

$534.00 K
ASBP annual total current liabilities is $534.00 thousand

Annual Accounts Payable

$172.80 K
ASBP annual accounts payable is $172.80 thousand

Debt

Annual Total Debt

$360.60 K
ASBP annual total debt is $360.60 thousand

Annual Total Debt 1-Year Change

+1187.86%
ASBP annual total debt is up +1187.86% year-on-year

Annual Long Term Debt

-
ASBP annual long term debt value is unknown

Annual Short Term Debt

$360.60 K
ASBP annual short term debt is $360.60 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$358.60 K
ASBP annual total expenses is $358.60 thousand

Annual Operating Expenses

$358.60 K
ASBP annual total operating expenses is $358.60 thousand

Annual Cost Of Goods Sold

-
ASBP annual cost of goods sold value is unknown

Annual SGA

$286.50 K
ASBP annual SGA is $286.50 thousand

Annual D&A

$0.00
ASBP annual depreciation & amortization is $0.00

Annual Interest Expense

$0.00
ASBP annual interest expense is $0.00

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$87.00 K
ASBP annual cash flow from operations is $87.00 thousand

Annual CFO 1-Year Change

+160.88%
ASBP annual cash flow from operations is up +160.88% year-on-year

Annual CFI

-$75.90 K
ASBP annual cash flow from investing activities is -$75.90 thousand

Annual CFI 1-Year Change

+98.45%
ASBP annual cash flow from investing activities is up +98.45% year-on-year

Annual CFF

$0.00
ASBP annual cash flow from financing activities is $0.00

Annual CFF 1-Year Change

-100%
ASBP annual cash flow from financing activities is down -100% year-on-year

Free CashFlow

Annual FCF

$11.10 K
ASBP annual free cash flow is $11.10 thousand

Annual FCF 1-Year Change

+100.22%
ASBP annual free cash flow is up +100.22% year-on-year

CAPEX

Annual CAPEX

-
ASBP annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
ASBP annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

CASI logo
CASI Pharmaceuticals (CASI)
OS Therapies Incorporated (OSTX)
HBIO logo
Harvard Bioscience (HBIO)
TPST logo
Tempest Therapeutics (TPST)
MODD logo
Modular Medical (MODD)
ATNM logo
Actinium Pharmaceuticals (ATNM)
GBIO logo
Generation Bio Co (GBIO)
LVTX logo
LAVA Therapeutics NV (LVTX)
SHLT logo
SHL Telemedicine (SHLT)

FAQ

  • What is the ticker symbol for Aspire BioPharma?
  • Does Aspire BioPharma pay dividends?
  • What sector is Aspire BioPharma in?
  • What industry is Aspire BioPharma in?
  • What country is Aspire BioPharma based in?
  • When did Aspire BioPharma go public?
  • Is Aspire BioPharma in the S&P 500?
  • Is Aspire BioPharma in the NASDAQ 100?
  • Is Aspire BioPharma in the Dow Jones?
  • When does Aspire BioPharma report earnings?

What is the ticker symbol for Aspire BioPharma?

The ticker symbol for Aspire BioPharma is NASDAQ:ASBP

Does Aspire BioPharma pay dividends?

No, Aspire BioPharma does not pay dividends

What sector is Aspire BioPharma in?

Aspire BioPharma is in the Healthcare sector

What industry is Aspire BioPharma in?

Aspire BioPharma is in the Biotechnology industry

What country is Aspire BioPharma based in?

Aspire BioPharma is headquartered in United States

When did Aspire BioPharma go public?

Aspire BioPharma's initial public offering (IPO) was on April 11, 2022

Is Aspire BioPharma in the S&P 500?

No, Aspire BioPharma is not included in the S&P 500 index

Is Aspire BioPharma in the NASDAQ 100?

No, Aspire BioPharma is not included in the NASDAQ 100 index

Is Aspire BioPharma in the Dow Jones?

No, Aspire BioPharma is not included in the Dow Jones index

When does Aspire BioPharma report earnings?

The date for Aspire BioPharma's next earnings report has not been announced yet